Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of SDD versus SOD on antibiotic resistance in ICU patients
NL-OMON28926Not yet recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Jun 2009
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Open-label trial of colistin, tobramycin, amphotericin b and cefotaxime in antibiotic-resistant organism colonization (2 arms), sponsored by University Medical Center Utrecht. Primary endpoint: Point prevalence of rectal and respiratory colonization with resistant bacteria. Planned start Jun 2009; status: not yet recruiting.
02
Drugs
colistintobramycinamphotericin bcefotaxime
03
Conditions
antibiotic-resistant organism colonization
Beyond the preview
Go deeper on NL-OMON28926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28926.